ProMIS Neurosciences Inc. Common Shares (ON) (PMN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for ProMIS Neurosciences Inc. Common Shares (ON), updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$11.07
+14.36% today
Market cap
$87M
Overall quality
—
Kronos AI 30-day
+12.4%
8 of 8 simulated paths end higher
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $87M. It trades at $11.07, up 14.36% today. 5 analysts' average target of $43.00 implies +288.4% from today's price. Kronos AI's 30-day forecast is +12.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $43.00 |
| Low – high | $18.00 – $100.00 |
| Analysts | 5 |
| Upside to average | +288.4% |
Kronos AI 30-day forecast
| Expected close | $10.88 (+12.4%) |
| Likely range | +6.1% … +31.2% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.